Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Cell Medicine|March 23, 2016
Resident Endothelial Progenitor Cells From Human Placenta Have Greater Vasculogenic Potential Than Circulating Endothelial Progenitor Cells From Umbilical Cord BloodBrian M Rapp, M Reza Saadatzedeh, Richard H Ofstein, et al.
Stem Cells (Dayton, Ohio)|October 21, 2014
Human adipose-derived stem cells ameliorate cigarette smoke-induced murine myelosuppression via secretion of TSG-6Jie Xie, Hal E Broxmeyer, Dongni Feng, et al.
Respiratory Research|June 2, 2018
Rapid clearance of heavy chain-modified hyaluronan during resolving acute lung injuryKevin Ni, Amar Gill, Victor Tseng, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2010
Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smokingKelly S Schweitzer, Brian H Johnstone, Jana Garrison, et al.
Cureus|June 3, 2024
Multidisciplinary Management Strategies for Long COVID: A Narrative ReviewChristian Prusinski, Dan Yan, Johana Klasova, et al.
Cardiovascular Research|August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular useDoris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Circulation Research|April 29, 2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure)Roberto Bolli, Joshua M Hare, Keith L March, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
Pageof 11